Premium
The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
Author(s) -
Huang SM,
Zhang L,
Giacomini K M
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2009.236
Subject(s) - food and drug administration , drug development , medicine , business , pharmacology , drug
The US Food and Drug Administration–led Critical Path Initiative, launched in 2004, has resulted in an array of activities focused on the sciences that support the development of human medical products. 1 These activities include the development of new scientific tools, such as in vitro testing, qualified biomarkers of drug safety, and innovative new methods in study design and data analysis. 2 As a result of the Critical Path Initiative and enormous advances in the field of membrane transporters, the International Transporter Consortium was formed. Clinical Pharmacology & Therapeutics (2010) 87 1, 32–36. doi: 10.1038/clpt.2009.236